<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01647646</url>
  </required_header>
  <id_info>
    <org_study_id>97083</org_study_id>
    <nct_id>NCT01647646</nct_id>
  </id_info>
  <brief_title>Real Life Effectiveness in Patients With Not Optimally Controlled Asthma</brief_title>
  <official_title>Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Far Eastern Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Far Eastern Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In real life, the investigators will be using different strategies including SMART therapy or
      other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. All not-well controlled asthma patients would include the study.

        2. We will compare three ways of asthma control including SMART, fixed doses with regular
           doses and fixed doses with higher doses

        3. We will evaluate the efficacy/safety for these not-well controlled patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the percentage of asthma total and well control</measure>
    <time_frame>one year</time_frame>
    <description>F/U clinical asthma control status and percentage of Acute exacerbation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of asthma acute exacerbation</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Symbicort</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>We will evaluate the efficacy fot Symbicort use. The usage was 2 doses bid for one year period.
Intervention drug: Seretide fixed doses therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Seretide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In non-well asthma controlled patients, experimental study with Seretide regular doses (125 2 doses bid for one year) and higher doses (250 2 doses bid) for one year</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Seretide</intervention_name>
    <description>Using Symbicort and Seretide for asthma control measurements Compared with efficacy and safety</description>
    <arm_group_label>Symbicort</arm_group_label>
    <arm_group_label>Seretide</arm_group_label>
    <other_name>Symbicort compared with Seretide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  asthma not well control

        Exclusion Criteria:

          -  COPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2012</study_first_submitted>
  <study_first_submitted_qc>July 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2012</study_first_posted>
  <last_update_submitted>July 23, 2012</last_update_submitted>
  <last_update_submitted_qc>July 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Far Eastern Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Shih-Lung Cheng</investigator_full_name>
    <investigator_title>Chief, Division of Pulmonary Medicine</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>SMART</keyword>
  <keyword>fixed dose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
    <mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

